KYTHERA Biopharmaceuticals to Present at the Goldman Sachs 36th Annual Global Healthcare Conference

20:00 EDT 2 Jun 2015 | Globe Newswire

WESTLAKE VILLAGE, Calif., June 03, 2015 (GLOBE NEWSWIRE) -- KYTHERA Biopharmaceuticals, Inc. (Nasdaq:KYTH) today announced that John Smither, chief financial officer, will present at the Goldman Sachs 36th Annual Global Healthcare Conference.

Event:        Goldman Sachs 36th Annual Global Healthcare Conference
Date:          Tuesday, June 9, 2015
Time:         2:00 p.m. PT

A live webcast will be available under the Investors section of the Company’s website at The presentation will be archived on the website and will be available for at least 14 days.


KYTHERA Biopharmaceuticals, Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of novel prescription products for the aesthetic medicine market. Its lead product, KYBELLA™ (deoxycholic acid), is the first and only approved injectable drug for contouring moderate to severe submental fullness, a condition that is commonly referred to as a double chin. KYTHERA is also developing KYTH-105 (setipiprant), an early-stage candidate for the prevention of male pattern baldness. KYTHERA’s longer-term strategy is to leverage its biotechnology and aesthetics experience to expand its product portfolio and pipeline. KYTHERA has submitted regulatory filings for ATX-101 in Canada, Switzerland and Australia. Find more information at


Investor Contact:
Heather Rowe, Director, Investor Relations
Tel: (818) 587- 4559

Primary Logo


More From BioPortfolio on "KYTHERA Biopharmaceuticals to Present at the Goldman Sachs 36th Annual Global Healthcare Conference"

Quick Search


Relevant Topics

Health care (or healthcare) is the diagnosis, treatment, and prevention of disease, illness, injury, and other physical and mental impairments in humans. Health care is delivered by practitioners in medicine, chiropractic, dentistry, nursing, pharmacy, a...

Biotechnology Products
BioPortfolio lists over 550 biotechnology products - please open Direct topic pages: Actos Advair Biopharmaceuticals Biosimilars Biotherapeutics GMO Crops Lipitor ...

Biopharmaceuticals are medical drugs produced using biotechnology. They include proteins (including antibodies), nucleic acids (DNA, RNA or antisense oligonucleotides) and living microorganisms like virus and bacteria where the virulance of viruses and b...